96 related articles for article (PubMed ID: 17357324)
1. Osteoprotegerin and C-telopeptide of type I collagen in Polish healthy children and adolescents.
Gajewska J; Ambroszkiewicz J; Laskowska-Klita T
Adv Med Sci; 2006; 51():269-72. PubMed ID: 17357324
[TBL] [Abstract][Full Text] [Related]
2. [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].
Ambroszkiewicz J; Gajewska J; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Nowacka M; Milanowski A
Pol Merkur Lekarski; 2008 Jul; 25(145):57-60. PubMed ID: 18839616
[TBL] [Abstract][Full Text] [Related]
3. [Some bone turnover markers in serum of healthy children and adolescents in relation to age and gender].
Gajewska J; Ambroszkiewicz J; Laskowska-Klita T
Wiad Lek; 2005; 58(9-10):476-80. PubMed ID: 16529055
[TBL] [Abstract][Full Text] [Related]
4. Serum markers of bone turnover in children and adolescents with classic galactosemia.
Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
[TBL] [Abstract][Full Text] [Related]
5. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
6. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
Mikosch P; Igerc I; Kudlacek S; Woloszczuk W; Gallowitsch HJ; Kresnik E; Stettner H; Grimm G; Lind P; Pietschmann P
Eur J Clin Invest; 2006 Aug; 36(8):566-73. PubMed ID: 16893379
[TBL] [Abstract][Full Text] [Related]
7. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
8. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents.
Mora S; Zamproni I; Cafarelli L; Giacomet V; Erba P; Zuccotti G; Viganò A
AIDS; 2007 May; 21(9):1129-35. PubMed ID: 17502723
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Koukoulis G; Kita M; Avramidis A
Horm Metab Res; 2008 Apr; 40(4):281-5. PubMed ID: 18275008
[TBL] [Abstract][Full Text] [Related]
10. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
[TBL] [Abstract][Full Text] [Related]
11. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women.
Holecki M; Zahorska-Markiewicz B; Janowska J; Nieszporek T; Wojaczyńska-Stanek K; Zak-Gołab A; Wiecek A
Obesity (Silver Spring); 2007 Aug; 15(8):1925-9. PubMed ID: 17712108
[TBL] [Abstract][Full Text] [Related]
12. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein.
Sennels HP; Jacobsen S; Jensen T; Hansen MS; Ostergaard M; Nielsen HJ; Sørensen S
Scand J Clin Lab Invest; 2007; 67(8):821-35. PubMed ID: 17852826
[TBL] [Abstract][Full Text] [Related]
13. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
14. The effect of exercise and estrogen on osteoprotegerin in premenopausal women.
West SL; Scheid JL; De Souza MJ
Bone; 2009 Jan; 44(1):137-44. PubMed ID: 18929691
[TBL] [Abstract][Full Text] [Related]
15. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
Woo JH; Lee HJ; Sung IH; Kim TH
J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
[TBL] [Abstract][Full Text] [Related]
16. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
Xiang GD; Sun HL; Zhao LS
Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
[TBL] [Abstract][Full Text] [Related]
17. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents.
Wasilewska A; Rybi-Szuminska AA; Zoch-Zwierz W
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1099-104. PubMed ID: 20333868
[TBL] [Abstract][Full Text] [Related]
19. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
20. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
Uemura H; Yasui T; Miyatani Y; Yamada M; Hiyoshi M; Arisawa K; Irahara M
Menopause; 2008; 15(1):180-4. PubMed ID: 17545921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
